Literature DB >> 14643639

IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture.

Laura Mannonen1, Eveline Kamping, Tuula Penttilä, Mirja Puolakkainen.   

Abstract

Growth of Chlamydia pneumoniae during gamma interferon (IFN-gamma) induced persistent infection in epithelial (HL) and monocyte-macrophage (Mono Mac 6) cell lines was studied by a quantitative real-time PCR and passage. When HL cultures were treated with IFN-gamma (25 U/ml), the replication of C. pneumoniae DNA was unaffected while differentiation into infectious elementary bodies (EB) was strongly inhibited, and in contrast to the untreated cultures, no second cycle of infection was observed. The estimated doubling time of C. pneumoniae genomes was 6-7 h in both IFN-gamma treated and untreated HL cultures. At 72 h post inoculation, most infectious EBs were released from untreated cultures, whereas in IFN-gamma treated HL cells >90% of C. pneumoniae genomes were in non-infectious form. A higher dose (1000 U/ml) of IFN-gamma was needed to restrict growth of C. pneumoniae in Mono Mac 6 cells. In untreated Mono Mac 6 cultures, the growth curve of C. pneumoniae resembled that observed in HL cells, except that no second cycle of infection could be detected. In IFN-gamma treated Mono Mac 6 cultures, the number of infectious C. pneumoniae EBs recovered decreased gradually after 3 days post inoculation, while C. pneumoniae genome load remained unaltered suggesting persistence of C. pneumoniae also in these cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14643639     DOI: 10.1016/j.micpath.2003.09.001

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Chlamydia pneumoniae infection in polarized epithelial cell lines.

Authors:  Liisa Törmäkangas; Eveliina Markkula; Kari Lounatmaa; Mirja Puolakkainen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

Review 2.  Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae.

Authors:  Wilhelmina M Huston; Christopher J Barker; Anu Chacko; Peter Timms
Journal:  J Bacteriol       Date:  2014-03-28       Impact factor: 3.490

3.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

4.  Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion.

Authors:  Juha T Korhonen; Mirja Puolakkainen; Reetta Häivälä; Tuula Penttilä; Anu Haveri; Eveliina Markkula; Riitta Lahesmaa
Journal:  Infect Immun       Date:  2012-01-03       Impact factor: 3.441

Review 5.  Laboratory diagnosis of persistent human chlamydial infection.

Authors:  Mirja Puolakkainen
Journal:  Front Cell Infect Microbiol       Date:  2013-12-17       Impact factor: 5.293

6.  A novel inhibitor of Chlamydophila pneumoniae protein kinase D (PknD) inhibits phosphorylation of CdsD and suppresses bacterial replication.

Authors:  Dustin L Johnson; Chris B Stone; David C Bulir; Brian K Coombes; James B Mahony
Journal:  BMC Microbiol       Date:  2009-10-14       Impact factor: 3.605

Review 7.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

8.  Intracellular survival and persistence of Chlamydia muridarum is determined by macrophage polarization.

Authors:  Eric Gracey; Aifeng Lin; Ali Akram; Basil Chiu; Robert D Inman
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 9.  Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.

Authors:  Marisa Di Pietro; Simone Filardo; Fiorenzo De Santis; Rosa Sessa
Journal:  Int J Mol Sci       Date:  2013-07-19       Impact factor: 5.923

10.  Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens.

Authors:  Maaret Nummi; Laura Mannonen; Mirja Puolakkainen
Journal:  Springerplus       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.